Trademark: KYH 2377267
Word
KYH
ID
2377267
Trademark Type
Figurative, Fancy
Status
Protected: Registered/protected
Application Date
10 March 2023
Registration Date
10 March 2023
Renewal Date
10 March 2033
Owner(s)
Service
Goods and Services:
Class 1:
Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for research, other experiments of minor health disorders to prevent them from becoming severe health disorders.
Stem cell preparations used for research of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for research, other experiments of minor health disorders to prevent them from becoming severe health disorders.
Class 5:
Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progress.
Stem cell preparations used for the treatment of peripheral neuropathy, peripheral vascular disease, critical limb ischemia, wound care, Class 1 - IV (end stage) heart diseases, angina pectoris, ischemic and dilated cardiomyopathy, COPD, idiopathic pulmonary hypertension and other diseases of ischemia; biomedical autologous and allogenic preparations used for the treatment of minor health disorders to prevent them from becoming severe health disorders, and to treat severe health disorders on an ongoing basis to slow, eliminate, or reverse their progress.
Class 42:
Research and development in the field of blood, blood products and blood testing; scientific research services in the field of blood and stem cells.
Research and development in the field of blood, blood products and blood testing; scientific research services in the field of blood and stem cells.
Class 44:
Services in the medical field, namely, extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components; services in the medical field, namely, selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the body.
Services in the medical field, namely, extracting, processing, culturing, testing, injecting or administering under medical supervision the products derived from blood and blood components; services in the medical field, namely, selecting, processing, manipulating, purging and storing stem cells from blood and adding regenerative cells to the body.